| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/28/1995 | WO1995025795A1 HUMAN trk RECEPTORS AND NEUROTROPHIC FACTOR INHIBITORS |
| 09/28/1995 | WO1995025793A1 Dyslipoproteinaemia-sensitised transgenic rabbit |
| 09/28/1995 | WO1995025792A1 Neuron promoter and uses |
| 09/28/1995 | WO1995025788A1 Novel mutated viruses, anti-viral compounds and novel methods of making vaccines |
| 09/28/1995 | WO1995025787A1 Methods for producing cytoplasmic male sterility in plants and use thereof in production of hybrid seed |
| 09/28/1995 | WO1995025785A1 EXPRESSION PLASMIDS REGULATED BY AN osmB PROMOTER |
| 09/28/1995 | WO1995025743A1 Enhanced secretion of polypeptides |
| 09/28/1995 | WO1995025740A1 Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules |
| 09/28/1995 | WO1995025592A1 Method of processing nucleic acids |
| 09/28/1995 | WO1995025543A1 Methods and compositions useful for inhibition of angiogenesis |
| 09/28/1995 | WO1995025542A1 Composition including a recombinant plasmid, and uses thereof as a vaccine and drug |
| 09/28/1995 | WO1995025535A1 Thyroxin-binding proteins |
| 09/28/1995 | WO1995025429A1 Mts gene, mutations therein, and methods for diagnosing cancer using mts gene sequence |
| 09/28/1995 | WO1995023860A3 KUNITZ DOMAIN INHIBITOR PROTEINS DERIVED FROM ALZHEIMER'S AMYLOID β-PROTEIN PRECURSOR INHIBITOR |
| 09/28/1995 | WO1995023855A3 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells |
| 09/28/1995 | WO1995022612A3 Genes and genetic elements associated with sensitivity to platinum-based drugs |
| 09/28/1995 | WO1995020666A3 Transgenic non-human mammals with progressive neurologic disease |
| 09/28/1995 | WO1995017523A3 Molecular diagnosis of familial adenomatous polyposis |
| 09/28/1995 | WO1995016048A3 Recombinant protein production in bovine adenovirus expression vector system |
| 09/28/1995 | WO1994025597A3 METHODS AND COMPOSITIONS FOR DETECTION OF $i(SALMONELLA) |
| 09/28/1995 | DE4438838C1 DNA-Sequenzen für Matrix-Metallproteasen, ihre Herstellung und ihre Verwendung DNA sequences for matrix metalloproteases, their preparation and their use |
| 09/28/1995 | DE4411588C1 Buffer, contg. betaine, for RNA- and DNA-polymerase reactions |
| 09/28/1995 | CA2186242A1 Gene-therapeutic process using antibiotic-resistance gene-free dna vectors |
| 09/28/1995 | CA2186235A1 Polypeptides for diagnosing infection with trypanosoma cruzi |
| 09/28/1995 | CA2186035A1 Thyroxin-binding proteins |
| 09/28/1995 | CA2185788A1 Neuron promoter and uses |
| 09/28/1995 | CA2185686A1 Dna encoding enzymes of the glycolitic pathway for use in alcohol producing yeast |
| 09/28/1995 | CA2185343A1 Enhanced secretion of polypeptides |
| 09/28/1995 | CA2184409A1 Recombinant adenoviruses coding for acidic fibroblast growth factor (afgf) |
| 09/28/1995 | CA2184408A1 Recombinant adenoviruses for glial maturation factor beta (gmf-.beta.) |
| 09/28/1995 | CA2184202A1 Dyslipoproteinaemia-sensitised transgenic rabbit |
| 09/28/1995 | CA2184200A1 Recombinant viruses, preparation and use in genic therapy |
| 09/28/1995 | CA2183647A1 Process for treating eucaryotic cells |
| 09/28/1995 | CA2163245A1 Methods for treating non-cotton-containing fabrics with cellulase |
| 09/28/1995 | CA2162147A1 Mts gene, mutations therein, and methods for diagnosing cancer using mts gene sequence |
| 09/27/1995 | EP0674009A2 Nucleic acid amplification method and apparatus |
| 09/27/1995 | EP0674006A1 Process of gene therapy using DNA vectors deprived of genes for resistance to antibiotics |
| 09/27/1995 | EP0674005A2 Non-reducing saccharide-forming enzyme, DNA encoding it, and their preparations and uses |
| 09/27/1995 | EP0674004A1 MSRV1 virus and pathogenic and/or infections agent MSRV2 linked to multiple sclerosis, their nucleic components and their applications |
| 09/27/1995 | EP0674003A2 Modulatory proteins of human CNS receptors |
| 09/27/1995 | EP0674000A2 Geranylgeranyl diphosphate synthase and DNA coding therefor |
| 09/27/1995 | EP0673948A1 Pepticles derived from a retrovirus of the HIV-group and their use |
| 09/27/1995 | EP0673679A1 Device for processing nucleic acids in cultures |
| 09/27/1995 | EP0673440A1 Mammalian muscle nad:arginine adp-ribosyltransferase |
| 09/27/1995 | EP0673437A1 Hepadnavirus polymerase having rna-dependent dna priming and reverse transcriptase activities and methods of measuring these activities |
| 09/27/1995 | EP0673432A1 Process for preparing clavulanic acid |
| 09/27/1995 | EP0673431A1 Gene therapy for cystic fibrosis |
| 09/27/1995 | EP0673430A1 Nucleotide sequence for treating cancer and infection |
| 09/27/1995 | EP0673429A1 Production of heterologous proteins in filamentous fungi |
| 09/27/1995 | EP0673428A1 Identification of compounds modulations protein/cell membrane association |
| 09/27/1995 | EP0673427A1 Process for immobilizing enzymes to the cell wall of a microbial cell by producing a fusion protein |
| 09/27/1995 | EP0673426A1 Platelet-activating factor acetylhydrolase |
| 09/27/1995 | EP0673425A1 Dna encoding chitin deacetylase |
| 09/27/1995 | EP0673424A1 Dna encoding 2-acyltransferases |
| 09/27/1995 | EP0673423A1 Viral resistance by plant transformation with a replicase portion of a plant virus genome |
| 09/27/1995 | EP0673422A1 Cells with altered betaine catabolism, their preparation and their use, in particular for producing metabolites or enzymes |
| 09/27/1995 | EP0673421A1 Allergenic proteins and peptides from johnson grass pollen |
| 09/27/1995 | EP0673420A1 Mammalian receptors for interleukin-10 (il-10) |
| 09/27/1995 | EP0673419A1 Stably transfected cell lines expressing gaba-a receptors |
| 09/27/1995 | EP0673418A1 Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications |
| 09/27/1995 | EP0673416A1 Oxalate decarboxylase |
| 09/27/1995 | EP0673415A1 Recombinant viral vector system |
| 09/27/1995 | EP0673414A1 Method for enhancing the differentiation of plant cells in culture |
| 09/27/1995 | EP0673390A1 Delta-like gene expressed in neuroendocrine tumors |
| 09/27/1995 | EP0673387A1 Materials and methods for control of pests |
| 09/27/1995 | EP0673386A1 Methods and compositions for detecting anti-hepatitis e virus activity |
| 09/27/1995 | EP0673385A1 Mammalian gap-43 compositions and methods of use |
| 09/27/1995 | EP0673382A1 METHODS AND COMPOSITIONS FOR cDNA SYNTHESIS |
| 09/27/1995 | EP0673260A1 Formation of triple helix complexes using a novel motif |
| 09/27/1995 | EP0673255A1 Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof |
| 09/27/1995 | EP0673252A1 Administration of oligonucleotides antisense to dopamine receptor mrna for diagnosis and treatment of neurological pathologies |
| 09/27/1995 | EP0631618A4 Culturing of hematopoietic stem cells and their genetic engineering. |
| 09/27/1995 | EP0582603A4 Carnation plants and methods for their transformation and propagation |
| 09/27/1995 | EP0348490B1 Treatment of type 2 diabetes mellitus |
| 09/27/1995 | CN1109260A A retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and uses of said vector |
| 09/26/1995 | US5453566 Antisense regulation of gene expression in plant/cells |
| 09/26/1995 | US5453491 Purified and comprising specified amino acid sequences; therapy for autoimmune disorders and eosinophilia |
| 09/26/1995 | US5453490 Production of recombinant human interleukin-1 inhibitor |
| 09/26/1995 | US5453489 Specific amino acid sequences; bind directly to fibronectin, reduces matrix assembly without affecting binding to cells; antitumor/wound healing agents |
| 09/26/1995 | US5453419 Xenopus laevis bone morphogenetic proteins and use thereof |
| 09/26/1995 | US5453374 Trigonopsis transformant producing D-amino acid oxidase |
| 09/26/1995 | US5453373 Protein C derivatives |
| 09/26/1995 | US5453372 Detergents |
| 09/26/1995 | US5453371 Bacterial collagenase gene of Vibrio alginolyticus |
| 09/26/1995 | US5453367 Transformation of hereditary material of plants |
| 09/26/1995 | US5453364 Recombinant poxvirus host range selection system |
| 09/26/1995 | US5453362 Herpes virus, viricides |
| 09/26/1995 | US5453361 Method for producing biologically active human brain derived neurotrophic factor |
| 09/26/1995 | US5453355 Oligonucleotides and methods for the detection of Neisseria gonorrhoeae |
| 09/26/1995 | CA2145623A1 Modulatory proteins of human cns receptors |
| 09/26/1995 | CA1337120C Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccines containing same |
| 09/23/1995 | CA2145029A1 Device for the treatment of nucleic acids in preparations |
| 09/21/1995 | WO1995025180A1 Isothermal strand displacement nucleic acid amplification |
| 09/21/1995 | WO1995025177A1 Electrochemical denaturation of double-stranded nucleic acid |
| 09/21/1995 | WO1995025173A1 Methods for identifying inhibitors of integrin activation |
| 09/21/1995 | WO1995025172A1 Recombinant antibody fragments which are synthesized and biotinylated in e. coli, their use in immunoassays and immunopurification techniques |
| 09/21/1995 | WO1995025171A2 Dna sequences for matrix metalloproteases, their production and use |
| 09/21/1995 | WO1995025170A1 NOVEL MUTEINS OF IFN-$g(b) |
| 09/21/1995 | WO1995025169A1 CHIMERIC GENE USING THE GENE OR cDNA OF INSULINE, SPECIALLY FOR THE GENE THERAPY OF DIABETES |
| 09/21/1995 | WO1995025168A1 Use of a recombinant inhibitor from erythrina caffra for purifying serine proteases |